TNF and depressive disorder: We thus hypothesized that the modulation of the immune-system by administration of anti-TNFα alters interoceptive signaling (i.e. ongoing monitoring of visceral bodily state [26–28], changing activity within prefrontal and limbic circuits of the brain which underlies specific cognitive and affective processing characteristic of depression patients with IBD.